Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Related story Can CBD Help Your Condition? CBD for hypertension.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

DECEMBER 2, 2021

IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Veriheal

NOVEMBER 21, 2023

Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.

Research and Development 93

Research and Development Consumption Education Data 93

Medicinal Marijuana Association

FEBRUARY 10, 2024

Implement research findings by consulting experts and translating data into practical actions. Research methodologies in cannabis studies can vary from observational studies that simply observe and report data, to randomized controlled trials that provide more robust evidence.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Related story Can CBD Help Your Condition? CBD for hypertension.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Veriheal

SEPTEMBER 13, 2022

Grow rooms require ventilation, lights, environmental controls, and other optimal environmental conditions in order for cannabis plants to thrive. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 108

Cultivation Data DEA Dispensary 108

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

AUGUST 27, 2021

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. Market condition.

Agriculture 105

Agriculture Data Environment Topical 105

Cannabis Law Report

MAY 26, 2022

Successful Behavioral Addiction Study Supplied Data for Patent. The successful completion of Awakn’s behavioral addictions study was announced last week and the data provided from the study was used in the patent filing. Current standard of care for all of these conditions is poor. Awakn Life Sciences Corp. (

Treatment 52

Treatment Research and Development Therapy Data 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

AUGUST 17, 2022

Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). However, the sample size is too small to make a 22% increased risk in hospitalization sound like such a significant finding.

Research and Development 96

Research and Development Topical Data Cannabis 96

Veriheal

JULY 12, 2021

As a veteran, being able to get past the PTSD involves transitioning out of the mental and emotional war zone, which is challenging and the reason why veterans seek out multiple methods to deal with the condition. A study conducted by Miriam Reisman reported that between 13.5% What Is The Latest Research for Veterans and PTSD?

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

The Cannigma

FEBRUARY 25, 2021

Often simply referred to as caryophyllene, this naturally occurring terpene is not just present in cannabis — it is quite common among plants, including many fruits, vegetables, herbs, and spices. In other words, BCP may aid in treating or preventing a multitude of conditions like infections, spasms, pain, and other neurologic conditions.

Terpenes 107

Terpenes Oil Cannabinoids Conditions 107

Cannabis Law Report

AUGUST 27, 2021

“This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. Chris Ray , PhD : Interventional Pain Physician.

Research and Development 98

Research and Development Treatment Media Medicine 98

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. The FDA recognizes psilocybin therapy as substantially better than present treatment options.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

OCTOBER 29, 2021

Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. diet, alcohol and tobacco consumption, and exercise) 11.

Research and Development 52

Research and Development Treatment Data Conditions 52

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. One of the most interesting aspects of the keto-canna connection is the overlap in conditions that may benefit from either cannabinoids, the ketogenic diet or both. Other conditions. The keto-canna connection: what do keto and cannabis have in common? 11 12 13 14.

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 In the present survey, 2.7 In the present survey, 2.7

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Canna Law Blog

JANUARY 17, 2023

A licensee automatically receives conditional approval after five days if a determination is still pending. Note: that link concerns the draft rule before the OLCC added the conditional approval “after five days” language to the proposed rule; but several other issues we identified remain in the rule as adopted).

Retail 70

Retail Cannabis Conditions Business 70

Cannabis Law Report

DECEMBER 7, 2021

Dravet syndrome is a rare presentation of intractable epileptic encephalopathies associated with pleomorphic seizure activity, usually before the one year of age, while Lennox-Gastaut syndrome is characterized by multiple drug-resistant seizure with a unique EEG pattern.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 25, 2022

Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. You must make sure that your condition qualifies and go through the application process. .

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

DECEMBER 29, 2021

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. Market condition.

CBD 52

CBD Data Decriminalization Environment 52

Cannabis Law Report

DECEMBER 21, 2021

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. Market condition.

Marijuana 52

Marijuana Data Environment Pharmaceutical 52

Cannabis Law Report

NOVEMBER 26, 2021

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. Market condition.

Pharmaceutical 52

Pharmaceutical Legalization Data Decriminalization 52

Cannabis Law Report

AUGUST 20, 2022

So, if you combine the fact that cannabis companies need more capital — much of which is seemingly drying up (at least for the moment) – with the practical challenges companies face to effectively restructure, the marketplace is presented with a condition of distress. billion (New Frontier Data). Where Do We Go From Here?

Wellness and Beauty 52

Wellness and Beauty Banking Decriminalization Data 52

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

DECEMBER 7, 2021

“Sadly, the illegal market is flourishing by undercutting the prices of legal businesses, which is bad for our economy as illegal businesses pay no taxes while subjecting workers to dangerous conditions and consumers to dangerous products. Source: [link].

Marijuana 52

Marijuana Retail Legislation Business 52

Veriheal

SEPTEMBER 12, 2022

Cannabis has been proving its therapeutic potential as a treatment option for many diseases and conditions. Joining amongst the ranks of protecting your skin from free radicals and protecting and improving neuroplasticity, as a condition which cannabis can assist with protecting you from is liver cancer, specifically hepatocellular carcinoma.

Research and Development 57

Research and Development Oil Treatment Patients 57

Veriheal

JULY 29, 2022

After analyzing 2021 seizure data, the UNODC also observed a potential increase in cocaine production and trafficking beyond the two biggest markets of Europe and North America into Africa and Asia. Numerous other studies have also supported cannabis’ ability to alleviate, not worsen, mental conditions.

Legalization 84

Legalization Consumption Cannabis Cannabinoids 84

Cannabis Law Report

JUNE 28, 2021

Based on government agency data, when viewed collectively, Ionic Brands manufacturing partners’ amount to the fifth-largest wholesale operator in Washington by revenue for the period of 2020. The acquisition of Cowlitz does not include the I-502 license as the state of Washington has limited ownership restrictions.

Business 95

Business Supply Chain Data Concentrates 95

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Cannabis Law Report

APRIL 21, 2022

Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022. A survey of veterinarians in the U.S.

Pets 52

Pets Research and Development Topical Consumption 52